18.1 C
New Delhi

Molnupiravir and Paxlovid , the heavily promoted antiviral drug ,Are they really safe ?

Date:

Share post:

So many new drugs come to the market and marketed as the panacea for the illness.
History reveals many such drugs had to be withdrawn due to toxicity.

If you have practiced medicine in the last 2 to 3 decades will remember many drugs that were withdrawn due to severe adverse effects.

Cisapride was used for heartburn,flatulence got withdrawn in 2003,it was shown to cause heart rhythm disturbances

Rofecoxib was a drug prescribed right and left for arthritic pain but later shown causing more heart attacks and thus withdrawn from the market.

This drug was marketed by Merck the same company promoting Molnupiravir the anti COVID pill which has been flagged up with problems specially to pregnant women and those planning to get pregnant

Terfenadine was used for allergy drug.It was withdrawn

Rosiglitazone an anti diabetic drug had 13,000 law suits as it was shown to cause more heart attacks.

When the modern Allopathy looks at Ayurveda as herbal medicine field,the reality is long list of medicines that were used heavily in allopathy but got withdrawn due to toxicities.

Why this post now?

Molnupiravir and Paxlovid two antiviral drugs promoted heavily for the COVID but we have to be cautious that no drug is safer and doctors should exercise caution in not going overboard to prescribe to everybody( an Indian phenomenon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Indian Govt trashes Canada report on Nijjar murder plot, calls it ‘ludicrous’

The government on Wednesday rubbished a Canadian newspaper report that alleged that Prime Minister Narendra Modi was aware...

Adani Group issues statement on ‘US Bribery Allegations’ on Gautam Adani, Scraps $600 Million Bond Deal

Adani Group founder and chairman, Gautam Adani, alongside seven other executives, has been indicted in the United States...

India ships first Akash Air Defence Missile system battery to Armenia

India marks another milestone in its defence export as it shipped the first Akash weapon system battery to...

Smartphone PLI revenue rings louder; 19x revenue boost for government in four years

The smartphone production-linked incentive (PLI) scheme has proven to be a significant revenue generator for the Indian government,...